Co-Authors
This is a "connection" page, showing publications co-authored by Zsolt Ablonczy and Craig Crosson.
Connection Strength
1.522
-
Human retinal pigment epithelium cells as functional models for the RPE in vivo. Invest Ophthalmol Vis Sci. 2011 Nov 04; 52(12):8614-20.
Score: 0.421
-
VEGF modulation of retinal pigment epithelium resistance. Exp Eye Res. 2007 Dec; 85(6):762-71.
Score: 0.315
-
Histone Deacetylase Inhibition Restores Retinal Pigment Epithelium Function in Hyperglycemia. PLoS One. 2016; 11(9):e0162596.
Score: 0.148
-
Progressive Early Breakdown of Retinal Pigment Epithelium Function in Hyperglycemic Rats. Invest Ophthalmol Vis Sci. 2016 05 01; 57(6):2706-13.
Score: 0.144
-
Receptor mediated disruption of retinal pigment epithelium function in acute glycated-albumin exposure. Exp Eye Res. 2015 Aug; 137:50-6.
Score: 0.135
-
Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo. Invest Ophthalmol Vis Sci. 2014 Apr 09; 55(4):2269-75.
Score: 0.125
-
C-type natriuretic peptide protects the retinal pigment epithelium against advanced glycation end product-induced barrier dysfunction. J Pharmacol Exp Ther. 2013 Jan; 344(1):96-102.
Score: 0.113
-
Pigment epithelium-derived factor maintains retinal pigment epithelium function by inhibiting vascular endothelial growth factor-R2 signaling through gamma-secretase. J Biol Chem. 2009 Oct 30; 284(44):30177-86.
Score: 0.091
-
Evidence of a novel mechanism for partial ?-secretase inhibition induced paradoxical increase in secreted amyloid ? protein. PLoS One. 2014; 9(3):e91531.
Score: 0.031